Recordati produces active ingredients for its own proprietary pharmaceuticals, active ingredients and intermediates for the generic drugs market and is engaged in the exclusive/custom manufacturing business serving major innovator big and emerging pharma organizations as well as major generic pharma organizations all over the world.
Recordati exports around 90% of its production of API’s and intermediates selling directly in over 50 countries.
For our customers in the Unites States and Canada:
Recordati Rare Diseases
100 Corporate Drive
Lebanon, NJ 08833 USA
Tel. +1 908 236 0888
Fax +1 908 236 0028